Skip to contentS
SeaStar Medical Holding Corp
S
ICUCWSeaStar Medical Holding Corp Q3 2024 · 10-Q
Revenue$68.00K$68.00K— vs Q3 2023 Net Income-$4.48M-$4.48MN/M vs Q3 2023 EPS Diluted-$1.10-$1.10N/M vs Q3 2023 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SeaStar Medical Holding Corp · CIK 1831868 · Engraved from SEC EDGAR
Operating Cash Flowderived-$5,002,000N/M Margins · derivedGross margin100.0%
Operating margin-6552.9%
Net margin-6585.3%
ended Sep 30, 2024 · filed Nov 13, 2024 · 44 d after period end